Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level

Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4–20 ng/ml, respectively)] were investigate...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance imaging Vol. 24; no. 5; pp. 541 - 548
Main Authors Kumar, Virendra, Jagannathan, Naranamangalam R., Kumar, Rajeev, Das, Sharat C., Jindal, Lokesh, Thulkar, Sanjay, Gupta, Siddhartha D., Dwivedi, Sadanand N., Roell, Stefan, Hemal, Ashok K., Gupta, Narmada P.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.06.2006
Subjects
Online AccessGet full text
ISSN0730-725X
1873-5894
DOI10.1016/j.mri.2006.01.001

Cover

Abstract Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4–20 ng/ml, respectively)] were investigated using endorectal coil at 1.5 T prior to transrectal ultrasound (TRUS)-guided biopsy. Metabolite ratio [citrate/(choline+creatine)] and apparent diffusion coefficient (ADC) were calculated for identical voxels. In patients, voxels that showed lower metabolite ratio showed reduced ADC in the peripheral zone (PZ) of the prostate, and voxels with increased metabolite ratio showed higher ADC. Metabolite ratios were used to predict areas of malignancy if the ratio was <1.4 and if ADC value was <1.17×10 −3 mm 2/s. Patients in Group II had lower metabolite ratio and ADC in the PZ compared to controls and Group III. All 13 were positive for malignancy in MR, while 12 of 13 were positive on TRUS-guided sextant biopsy. In Group III, certain voxels of PZ that showed reduced metabolite ratio also showed lower ADC. A positive correlation was observed between metabolite ratio and ADC. MR predicted areas of malignancy in PZ in 15 of 20 patients; however, only six were positive on TRUS-guided biopsy perhaps due to high false-negative rate of TRUS-guided biopsy. Results show positive correlation between MRSI and DWI and their potential in detection of malignancy, thereby improving the diagnosis especially in patients with PSA level of 4–20 ng/ml.
AbstractList Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4-20 ng/ml, respectively)] were investigated using endorectal coil at 1.5 T prior to transrectal ultrasound (TRUS)-guided biopsy. Metabolite ratio [citrate/(choline+creatine)] and apparent diffusion coefficient (ADC) were calculated for identical voxels. In patients, voxels that showed lower metabolite ratio showed reduced ADC in the peripheral zone (PZ) of the prostate, and voxels with increased metabolite ratio showed higher ADC. Metabolite ratios were used to predict areas of malignancy if the ratio was <1.4 and if ADC value was <1.17 x 10(-3) mm(2)/s. Patients in Group II had lower metabolite ratio and ADC in the PZ compared to controls and Group III. All 13 were positive for malignancy in MR, while 12 of 13 were positive on TRUS-guided sextant biopsy. In Group III, certain voxels of PZ that showed reduced metabolite ratio also showed lower ADC. A positive correlation was observed between metabolite ratio and ADC. MR predicted areas of malignancy in PZ in 15 of 20 patients; however, only six were positive on TRUS-guided biopsy perhaps due to high false-negative rate of TRUS-guided biopsy. Results show positive correlation between MRSI and DWI and their potential in detection of malignancy, thereby improving the diagnosis especially in patients with PSA level of 4-20 ng/ml.Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4-20 ng/ml, respectively)] were investigated using endorectal coil at 1.5 T prior to transrectal ultrasound (TRUS)-guided biopsy. Metabolite ratio [citrate/(choline+creatine)] and apparent diffusion coefficient (ADC) were calculated for identical voxels. In patients, voxels that showed lower metabolite ratio showed reduced ADC in the peripheral zone (PZ) of the prostate, and voxels with increased metabolite ratio showed higher ADC. Metabolite ratios were used to predict areas of malignancy if the ratio was <1.4 and if ADC value was <1.17 x 10(-3) mm(2)/s. Patients in Group II had lower metabolite ratio and ADC in the PZ compared to controls and Group III. All 13 were positive for malignancy in MR, while 12 of 13 were positive on TRUS-guided sextant biopsy. In Group III, certain voxels of PZ that showed reduced metabolite ratio also showed lower ADC. A positive correlation was observed between metabolite ratio and ADC. MR predicted areas of malignancy in PZ in 15 of 20 patients; however, only six were positive on TRUS-guided biopsy perhaps due to high false-negative rate of TRUS-guided biopsy. Results show positive correlation between MRSI and DWI and their potential in detection of malignancy, thereby improving the diagnosis especially in patients with PSA level of 4-20 ng/ml.
Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4–20 ng/ml, respectively)] were investigated using endorectal coil at 1.5 T prior to transrectal ultrasound (TRUS)-guided biopsy. Metabolite ratio [citrate/(choline+creatine)] and apparent diffusion coefficient (ADC) were calculated for identical voxels. In patients, voxels that showed lower metabolite ratio showed reduced ADC in the peripheral zone (PZ) of the prostate, and voxels with increased metabolite ratio showed higher ADC. Metabolite ratios were used to predict areas of malignancy if the ratio was <1.4 and if ADC value was <1.17×10 −3 mm 2/s. Patients in Group II had lower metabolite ratio and ADC in the PZ compared to controls and Group III. All 13 were positive for malignancy in MR, while 12 of 13 were positive on TRUS-guided sextant biopsy. In Group III, certain voxels of PZ that showed reduced metabolite ratio also showed lower ADC. A positive correlation was observed between metabolite ratio and ADC. MR predicted areas of malignancy in PZ in 15 of 20 patients; however, only six were positive on TRUS-guided biopsy perhaps due to high false-negative rate of TRUS-guided biopsy. Results show positive correlation between MRSI and DWI and their potential in detection of malignancy, thereby improving the diagnosis especially in patients with PSA level of 4–20 ng/ml.
Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen (PSA) level. Forty subjects [controls (Group I) and patients (Groups II and III with PSA >20 and 4-20 ng/ml, respectively)] were investigated using endorectal coil at 1.5 T prior to transrectal ultrasound (TRUS)-guided biopsy. Metabolite ratio [citrate/(choline+creatine)] and apparent diffusion coefficient (ADC) were calculated for identical voxels. In patients, voxels that showed lower metabolite ratio showed reduced ADC in the peripheral zone (PZ) of the prostate, and voxels with increased metabolite ratio showed higher ADC. Metabolite ratios were used to predict areas of malignancy if the ratio was <1.4 and if ADC value was <1.17 x 10(-3) mm(2)/s. Patients in Group II had lower metabolite ratio and ADC in the PZ compared to controls and Group III. All 13 were positive for malignancy in MR, while 12 of 13 were positive on TRUS-guided sextant biopsy. In Group III, certain voxels of PZ that showed reduced metabolite ratio also showed lower ADC. A positive correlation was observed between metabolite ratio and ADC. MR predicted areas of malignancy in PZ in 15 of 20 patients; however, only six were positive on TRUS-guided biopsy perhaps due to high false-negative rate of TRUS-guided biopsy. Results show positive correlation between MRSI and DWI and their potential in detection of malignancy, thereby improving the diagnosis especially in patients with PSA level of 4-20 ng/ml.
Author Kumar, Virendra
Kumar, Rajeev
Gupta, Siddhartha D.
Dwivedi, Sadanand N.
Hemal, Ashok K.
Jindal, Lokesh
Roell, Stefan
Gupta, Narmada P.
Das, Sharat C.
Jagannathan, Naranamangalam R.
Thulkar, Sanjay
Author_xml – sequence: 1
  givenname: Virendra
  surname: Kumar
  fullname: Kumar, Virendra
  organization: Department of NMR, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 2
  givenname: Naranamangalam R.
  surname: Jagannathan
  fullname: Jagannathan, Naranamangalam R.
  email: jagan1954@hotmail.com, nrjgj@yahoo.co.in
  organization: Department of NMR, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 3
  givenname: Rajeev
  surname: Kumar
  fullname: Kumar, Rajeev
  organization: Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 4
  givenname: Sharat C.
  surname: Das
  fullname: Das, Sharat C.
  organization: Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 5
  givenname: Lokesh
  surname: Jindal
  fullname: Jindal, Lokesh
  organization: Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 6
  givenname: Sanjay
  surname: Thulkar
  fullname: Thulkar, Sanjay
  organization: Department of Radio-diagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 7
  givenname: Siddhartha D.
  surname: Gupta
  fullname: Gupta, Siddhartha D.
  organization: Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 8
  givenname: Sadanand N.
  surname: Dwivedi
  fullname: Dwivedi, Sadanand N.
  organization: Department of Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 9
  givenname: Stefan
  surname: Roell
  fullname: Roell, Stefan
  organization: Siemens AG, Medical Solutions MR, Application Development Spectroscopy (MREA-MRS), 91050 Erlangen, Germany
– sequence: 10
  givenname: Ashok K.
  surname: Hemal
  fullname: Hemal, Ashok K.
  organization: Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
– sequence: 11
  givenname: Narmada P.
  surname: Gupta
  fullname: Gupta, Narmada P.
  organization: Department of Urology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16735174$$D View this record in MEDLINE/PubMed
BookMark eNqFkEFLHDEUgIMoutr-AC8lp95mmjeTTGbwtKxaBUGhLfSWZjNvMNtMRpPsiv--2a5F8GBPeZDvCy_fMdn3k0dCToGVwKD5sirHYMuKsaZkUDIGe2QGrawL0XZ8n8yYrFkhK_HziBzHuGKMiaoWh-QIGlkLkHxGfi2mENDpZCdPl5ieED0dMenl5GxCGrY3kWrf0_n5gm60W2Ok00AfwhSTzoTd8p4-2XSfZxNQR-zp3bc5dbhB94EcDNpF_PhynpAflxffF1fFze3X68X8pjCcQSpaPkjsB2MqwYXR2HQS6w4FR910OBiQy6pruzwAF9hgCygG3vDKyApEXdUn5PPu3bzYY94xqdFGg85pj9M6qqZlNYDoMvjpBVwvR-zVQ7CjDs_qX5MMwA4w-Ysx4PCKMLXtrlYqd1fb7oqByt2zI984xqa_UVPQ1r1rnu1MzHE2FoOKxqI32NuAJql-su_a3RvbOOut0e43Pv_H_QP5A6_f
CitedBy_id crossref_primary_10_1002_jmri_22421
crossref_primary_10_2217_fon_13_14
crossref_primary_10_2214_AJR_11_7805
crossref_primary_10_2463_mrms_2012_0054
crossref_primary_10_1016_j_urolonc_2019_10_019
crossref_primary_10_1016_j_radonc_2023_109677
crossref_primary_10_1002_jmri_21898
crossref_primary_10_1002_nbm_2956
crossref_primary_10_1016_j_acra_2010_07_009
crossref_primary_10_1148_radiol_2462070368
crossref_primary_10_1016_S0221_0363_10_70157_8
crossref_primary_10_1002_mrm_27616
crossref_primary_10_1016_S0221_0363_08_73909_X
crossref_primary_10_1016_j_cct_2015_02_008
crossref_primary_10_1016_j_mri_2008_01_030
crossref_primary_10_1016_j_urolonc_2009_03_032
crossref_primary_10_1148_radiol_2471061828
crossref_primary_10_4236_ami_2013_33005
crossref_primary_10_2214_AJR_13_12277
crossref_primary_10_1016_j_mri_2011_09_024
crossref_primary_10_1097_MOU_0b013e3282f19d01
crossref_primary_10_2214_AJR_09_2651
crossref_primary_10_2214_AJR_10_5700
crossref_primary_10_4329_wjr_v16_i10_497
crossref_primary_10_1002_nbm_1083
crossref_primary_10_1038_nrclinonc_2009_18
crossref_primary_10_3109_0284186X_2010_530688
crossref_primary_10_1002_jmri_21117
crossref_primary_10_1111_j_1442_2042_2012_02995_x
crossref_primary_10_2214_AJR_09_3557
crossref_primary_10_1002_jmri_23809
crossref_primary_10_2214_AJR_09_2540
crossref_primary_10_1016_j_pnmrs_2018_01_001
crossref_primary_10_1016_j_ejmp_2012_10_002
crossref_primary_10_4329_wjr_v8_i1_21
crossref_primary_10_1007_s00330_014_3479_0
crossref_primary_10_1007_s00330_010_1960_y
crossref_primary_10_1097_RMR_0b013e3181aa6b50
crossref_primary_10_1021_cr9004007
crossref_primary_10_1002_jmri_21388
crossref_primary_10_1016_j_eururo_2008_10_019
crossref_primary_10_1016_j_mri_2016_05_006
crossref_primary_10_1111_j_1464_410X_2009_08446_x
crossref_primary_10_1002_nbm_3452
crossref_primary_10_1002_jmri_21503
crossref_primary_10_1097_RCT_0b013e31823f6263
crossref_primary_10_1016_j_ejrnm_2010_08_004
crossref_primary_10_1007_s10334_008_0122_6
crossref_primary_10_1002_nbm_1114
crossref_primary_10_3310_hta22390
crossref_primary_10_1155_2018_5906471
crossref_primary_10_1148_radiol_2482070157
Cites_doi 10.1006/jmra.1996.0242
10.1016/S0730-725X(99)00006-5
10.1097/00041327-200206000-00013
10.1002/mrm.1910370212
10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B
10.1046/j.1464-410X.2000.00592.x
10.1118/1.1593633
10.1016/S0360-3016(01)02609-8
10.1016/S0022-5347(05)64542-9
10.1016/S0033-8389(05)70150-0
10.1002/jcb.10636
10.1002/nbm.793
10.1002/(SICI)1099-1492(199902)12:1<39::AID-NBM543>3.0.CO;2-1
10.1002/jmri.20251
10.1007/s002610000142
10.1002/mrm.1910360305
10.1148/radiol.2291021383
10.1159/000012183
10.1002/jmri.10139
10.1081/CNV-100103849
10.1002/mrm.20190
10.1097/01.ju.0000094958.23276.c4
10.1002/jmri.1076
10.3322/canjclin.51.1.15
10.1016/S0730-725X(98)00110-6
10.1148/radiology.198.3.8628874
10.1002/mrm.1910290302
10.1007/s00240-003-0372-8
10.1016/S0090-4295(99)80016-8
10.1002/mrm.1298
10.1002/mrm.1910290109
10.1002/jmri.10172
10.1148/radiology.178.3.1994421
10.1016/S0022-5347(17)64003-5
10.1016/S0730-725X(97)00182-3
10.1002/jmri.10140
ContentType Journal Article
Copyright 2006 Elsevier Inc.
Copyright_xml – notice: 2006 Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.mri.2006.01.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-5894
EndPage 548
ExternalDocumentID 16735174
10_1016_j_mri_2006_01_001
S0730725X06000257
Genre Controlled Clinical Trial
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29M
3O-
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABDPE
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABNEU
ABOCM
ABUDA
ABWVN
ABXDB
ACDAQ
ACFVG
ACGFS
ACIEU
ACIUM
ACLOT
ACNNM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AIVDX
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEI
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OGIMB
OI~
OU0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPC
SPCBC
SSH
SSQ
SSU
SSZ
T5K
WUQ
XPP
Z5R
ZGI
ZMT
~G-
~HD
~S-
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
G8K
LCYCR
RIG
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c401t-84f7edfcc2545cae697e39e54ea69efc17b2989fc1145e6e81e5f4642c7215323
IEDL.DBID AIKHN
ISSN 0730-725X
IngestDate Thu Oct 02 14:14:56 EDT 2025
Wed Feb 19 01:42:42 EST 2025
Wed Oct 01 03:21:23 EDT 2025
Thu Apr 24 22:57:46 EDT 2025
Fri Feb 23 02:27:52 EST 2024
Tue Oct 14 19:36:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Prostate-specific antigen (PSA)
Apparent diffusion coefficient (ADC)
Diffusion-weighted imaging (DWI)
Magnetic resonance spectroscopic imaging (MRSI)
Prostate cancer
Citrate/(Cho+Cr) ratio
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c401t-84f7edfcc2545cae697e39e54ea69efc17b2989fc1145e6e81e5f4642c7215323
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 16735174
PQID 68031159
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_68031159
pubmed_primary_16735174
crossref_primary_10_1016_j_mri_2006_01_001
crossref_citationtrail_10_1016_j_mri_2006_01_001
elsevier_sciencedirect_doi_10_1016_j_mri_2006_01_001
elsevier_clinicalkey_doi_10_1016_j_mri_2006_01_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-06-01
PublicationDateYYYYMMDD 2006-06-01
PublicationDate_xml – month: 06
  year: 2006
  text: 2006-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Magnetic resonance imaging
PublicationTitleAlternate Magn Reson Imaging
PublicationYear 2006
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Lowry, Liney, Turnbull, Manton, Blackband, Horsman (bib21) 1996; 36
Greenlee, Hill-Harmon, Murray, Thun (bib37) 2001; 51
Swanson, Vigneron, Tran, Kurhanewicz (bib27) 2001; 19
Tempany, Haker (bib4) 2003
Bartolozzi, Menchi, Ortori, Lencioni (bib6) 2001; 26
Liney, Turnbull, Knowles (bib17) 1999; 12
Schiebler, White, Maygarden, Mohler (bib40) 1993; 29
Chan, Wells, Mulkern, Haker, Zhang, Zou, Maier (bib11) 2003; 30
Karam, Mason, Koeneman, Antich, Benaim, Hsieh (bib1) 2003; 90
Kurhanewicz, Vigneron, Hricak, Narayan, Carroll, Nelson (bib31) 1996; 198
Sinha, Sinha (bib13) 2004; 52
Hsing, Devesa (bib36) 2000; 85
Engelbrecht, Barentsz, Jager (bib39) 2000; 86
Mescher, Tannus, Johnson, Garwood (bib30) 1996; 123
Kurhanewicz, Swanson, Nelson, Vigneron (bib26) 2002; 16
Young (bib2) 2002; 168
Le Bihan, Mangin, Poupon, Clark, Pappata, Molko (bib8) 2001; 13
Zakian, Eberhardt, Hricak (bib28) 2003; 229
Sato, Naganawa, Nakamura, Kumada, Miura, Takizawa (bib33) 2005; 21
Kumar, Kumar, Jagannathan, Gupta, Hemal (bib14) 2004; 32
Issa (bib10) 2002; 16
Herminghaus, Pilatus, Moller-Hartmann, Raab, Lanfermann, Schlote (bib44) 2002; 15
Mukherji, Cheneverti, Castillo (bib9) 2002; 22
Schick, Bongers, Kurz, Jung, Pfeffer, Lutz (bib23) 1993; 29
(bib38) 2001
Kurhanewicz, Vigneron, Nelson, Hricak, MacDonald, Konety (bib22) 1995; 45
Heerschap, Jager, van der Graaf, Barentsz, Ruijs (bib19) 1997; 37
DiBiase, Hosseinzadeh, Gullapalli, Jacobs, Naslund, Sklar (bib25) 2002; 52
Schnall, Imai, Tomaszewski, Pollack, Lenkinski, Kressel (bib7) 1991; 178
Kumar V, Jagannathan NR, Kumar R, et al. Determination of apparent diffusion coefficient (ADC) in prostate of men with raised serum prostate specific antigen (PSA) or abnormal digital rectal examination (DRE) prior to transrectal ultrasound (TRUS) guided biopsy. [submitted for publication].
Garcia-Segura, Sanchez-Chapado, Ibarburen, Viano, Angulo, Gonzalez (bib16) 1999; 17
Thomas, Narayan, Kurhanewicz, Jajodia, Weiner (bib24) 1990; 87
Costello, Franklin (bib41) 2000; 59
Carter, Partin (bib42) 2002
Liney, Turnbull, Lowry, Turnbull, Knowles, Horsman (bib20) 1997; 15
Coakley, Qayyum, Kurhanewicz (bib3) 2003; 170
Walsh (bib29) 1986; vol. 2
Kim, Kim, Lee, Sung, Chung, Kim (bib18) 1998; 16
Gibbs, Tozer, Liney, Turnbull (bib12) 2001; 46
Hricak, Dooms, McNeal (bib35) 1987
Cooper, Farid (bib43) 1964; 92
Guo, Cai, Cai (bib34) 2002; 16
Hasumi, Suzuki, Oya, Ito, Kurokawa, Fukabori (bib15) 2002; 22
Yu, Hricak (bib5) 2000; 38
Sato (10.1016/j.mri.2006.01.001_bib33) 2005; 21
Yu (10.1016/j.mri.2006.01.001_bib5) 2000; 38
Karam (10.1016/j.mri.2006.01.001_bib1) 2003; 90
Walsh (10.1016/j.mri.2006.01.001_bib29) 1986; vol. 2
Kim (10.1016/j.mri.2006.01.001_bib18) 1998; 16
Issa (10.1016/j.mri.2006.01.001_bib10) 2002; 16
Hricak (10.1016/j.mri.2006.01.001_bib35) 1987
(10.1016/j.mri.2006.01.001_bib38) 2001
Chan (10.1016/j.mri.2006.01.001_bib11) 2003; 30
Sinha (10.1016/j.mri.2006.01.001_bib13) 2004; 52
Heerschap (10.1016/j.mri.2006.01.001_bib19) 1997; 37
Schiebler (10.1016/j.mri.2006.01.001_bib40) 1993; 29
Young (10.1016/j.mri.2006.01.001_bib2) 2002; 168
Swanson (10.1016/j.mri.2006.01.001_bib27) 2001; 19
Hasumi (10.1016/j.mri.2006.01.001_bib15) 2002; 22
Guo (10.1016/j.mri.2006.01.001_bib34) 2002; 16
Tempany (10.1016/j.mri.2006.01.001_bib4) 2003
Coakley (10.1016/j.mri.2006.01.001_bib3) 2003; 170
Bartolozzi (10.1016/j.mri.2006.01.001_bib6) 2001; 26
Schnall (10.1016/j.mri.2006.01.001_bib7) 1991; 178
DiBiase (10.1016/j.mri.2006.01.001_bib25) 2002; 52
Hsing (10.1016/j.mri.2006.01.001_bib36) 2000; 85
Kurhanewicz (10.1016/j.mri.2006.01.001_bib22) 1995; 45
10.1016/j.mri.2006.01.001_bib32
Carter (10.1016/j.mri.2006.01.001_bib42) 2002
Gibbs (10.1016/j.mri.2006.01.001_bib12) 2001; 46
Costello (10.1016/j.mri.2006.01.001_bib41) 2000; 59
Zakian (10.1016/j.mri.2006.01.001_bib28) 2003; 229
Cooper (10.1016/j.mri.2006.01.001_bib43) 1964; 92
Le Bihan (10.1016/j.mri.2006.01.001_bib8) 2001; 13
Kurhanewicz (10.1016/j.mri.2006.01.001_bib26) 2002; 16
Mukherji (10.1016/j.mri.2006.01.001_bib9) 2002; 22
Greenlee (10.1016/j.mri.2006.01.001_bib37) 2001; 51
Kurhanewicz (10.1016/j.mri.2006.01.001_bib31) 1996; 198
Schick (10.1016/j.mri.2006.01.001_bib23) 1993; 29
Liney (10.1016/j.mri.2006.01.001_bib17) 1999; 12
Mescher (10.1016/j.mri.2006.01.001_bib30) 1996; 123
Kumar (10.1016/j.mri.2006.01.001_bib14) 2004; 32
Thomas (10.1016/j.mri.2006.01.001_bib24) 1990; 87
Liney (10.1016/j.mri.2006.01.001_bib20) 1997; 15
Engelbrecht (10.1016/j.mri.2006.01.001_bib39) 2000; 86
Garcia-Segura (10.1016/j.mri.2006.01.001_bib16) 1999; 17
Herminghaus (10.1016/j.mri.2006.01.001_bib44) 2002; 15
Lowry (10.1016/j.mri.2006.01.001_bib21) 1996; 36
References_xml – volume: 90
  start-page: 473
  year: 2003
  end-page: 483
  ident: bib1
  article-title: Molecular imaging in prostate cancer
  publication-title: J Cell Biochem
– volume: 52
  start-page: 429
  year: 2002
  end-page: 438
  ident: bib25
  article-title: Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 22
  start-page: 118
  year: 2002
  end-page: 122
  ident: bib9
  article-title: Diffusion-weighted magnetic resonance imaging
  publication-title: J Neuroophthalmol
– volume: 17
  start-page: 755
  year: 1999
  end-page: 765
  ident: bib16
  article-title: In vivo proton magnetic resonance spectroscopy of diseased prostate, spectroscopic features of malignant versus benign pathology
  publication-title: Magn Reson Imaging
– volume: 168
  start-page: 914
  year: 2002
  end-page: 921
  ident: bib2
  article-title: The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905
  publication-title: J Urol
– volume: 32
  start-page: 36
  year: 2004
  end-page: 40
  ident: bib14
  article-title: Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate
  publication-title: Urol Res
– volume: 38
  start-page: 59
  year: 2000
  end-page: 85
  ident: bib5
  article-title: Imaging prostate cancer
  publication-title: Radiol Clin North Am
– start-page: 3058
  year: 2002
  ident: bib42
  article-title: Diagnosis and staging of prostate cancer
  publication-title: Campbell's urology
– volume: 59
  start-page: 269
  year: 2000
  end-page: 282
  ident: bib41
  article-title: The intermediary metabolism of the prostate, a key to understanding the pathogenesis and progression of prostate malignancy
  publication-title: Oncology
– volume: 92
  start-page: 533
  year: 1964
  end-page: 536
  ident: bib43
  article-title: The role of citric acid in the physiology of the prostate. 3. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy
  publication-title: J Urol
– volume: 46
  start-page: 1054
  year: 2001
  end-page: 1058
  ident: bib12
  article-title: Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate
  publication-title: Magn Reson Med
– volume: 170
  start-page: 69
  year: 2003
  end-page: 75
  ident: bib3
  article-title: Magnetic resonance imaging and spectroscopic imaging of prostate cancer
  publication-title: J Urol
– year: 2001
  ident: bib38
  article-title: National cancer registry program, consolidated report of the population based cancer registries
– volume: 85
  start-page: 60
  year: 2000
  end-page: 67
  ident: bib36
  article-title: International trends and patterns of prostate cancer incidence and mortality
  publication-title: Int J Cancer
– start-page: 35
  year: 2003
  ident: bib4
  article-title: Magnetic resonance-guided prostate biopsy
  publication-title: Image guided diagnosis and treatment of cancer
– volume: 45
  start-page: 459
  year: 1995
  end-page: 466
  ident: bib22
  article-title: Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone, detection via localized proton spectroscopy
  publication-title: Urology
– volume: vol. 2
  start-page: 1248
  year: 1986
  end-page: 1265
  ident: bib29
  article-title: Benign prostatic hyperplasia
  publication-title: Campbell's urology
– volume: 51
  start-page: 15
  year: 2001
  end-page: 36
  ident: bib37
  article-title: Cancer statistics
  publication-title: CA Cancer J Clin
– volume: 29
  start-page: 38
  year: 1993
  end-page: 43
  ident: bib23
  article-title: Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5T
  publication-title: Magn Reson Med
– volume: 16
  start-page: 451
  year: 2002
  end-page: 463
  ident: bib26
  article-title: Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer
  publication-title: J Magn Reson Imaging
– volume: 198
  start-page: 795
  year: 1996
  end-page: 805
  ident: bib31
  article-title: Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm
  publication-title: Radiology
– volume: 37
  start-page: 204
  year: 1997
  end-page: 213
  ident: bib19
  article-title: Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence
  publication-title: Magn Reson Med
– reference: Kumar V, Jagannathan NR, Kumar R, et al. Determination of apparent diffusion coefficient (ADC) in prostate of men with raised serum prostate specific antigen (PSA) or abnormal digital rectal examination (DRE) prior to transrectal ultrasound (TRUS) guided biopsy. [submitted for publication].
– volume: 13
  start-page: 534
  year: 2001
  end-page: 546
  ident: bib8
  article-title: Diffusion tensor imaging, concepts and applications
  publication-title: J Magn Reson Imaging
– volume: 16
  start-page: 172
  year: 2002
  end-page: 178
  ident: bib34
  article-title: Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging
  publication-title: J Magn Reson Imaging
– volume: 52
  start-page: 530
  year: 2004
  end-page: 537
  ident: bib13
  article-title: In vivo diffusion tensor imaging of the human prostate
  publication-title: Magn Reson Med
– volume: 178
  start-page: 797
  year: 1991
  end-page: 802
  ident: bib7
  article-title: Prostate cancer, local staging with endorectal surface coil MR imaging
  publication-title: Radiology
– volume: 16
  start-page: 196
  year: 2002
  end-page: 200
  ident: bib10
  article-title: In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging
  publication-title: J Magn Reson Imaging
– volume: 12
  start-page: 39
  year: 1999
  end-page: 44
  ident: bib17
  article-title: In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland
  publication-title: NMR Biomed
– volume: 229
  start-page: 241
  year: 2003
  end-page: 247
  ident: bib28
  article-title: Transition zone prostate cancer, metabolic characteristics at
  publication-title: Radiology
– volume: 15
  start-page: 385
  year: 2002
  end-page: 392
  ident: bib44
  article-title: Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors
  publication-title: NMR Biomed
– volume: 26
  start-page: 111
  year: 2001
  end-page: 122
  ident: bib6
  article-title: Endorectal magnetic resonance imaging in local staging of prostate carcinoma
  publication-title: Abdom Imaging
– volume: 30
  start-page: 2390
  year: 2003
  end-page: 2398
  ident: bib11
  article-title: Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging, a multichannel statistical classifier
  publication-title: Med Phys
– volume: 16
  start-page: 1281
  year: 1998
  end-page: 1288
  ident: bib18
  article-title: In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia, localized proton magnetic resonance spectroscopy using external-body surface coil
  publication-title: Magn Reson Imaging
– volume: 21
  start-page: 258
  year: 2005
  end-page: 262
  ident: bib33
  article-title: Differentiation of non-cancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate
  publication-title: J Magn Reson Imaging
– volume: 123
  start-page: 226
  year: 1996
  end-page: 229
  ident: bib30
  article-title: Solvent suppression using selective echo dephasing
  publication-title: J Magn Reson A
– start-page: 148
  year: 1987
  ident: bib35
  article-title: MR imaging of the prostate gland: normal anatomy
  publication-title: AJR Am J Roentgenol
– volume: 87
  start-page: 610
  year: 1990
  end-page: 619
  ident: bib24
  publication-title: J Magn Reson
– volume: 86
  start-page: 123
  year: 2000
  end-page: 134
  ident: bib39
  article-title: Prostate cancer staging using imaging
  publication-title: BJU Int
– volume: 22
  start-page: 1205
  year: 2002
  end-page: 1208
  ident: bib15
  article-title: MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer
  publication-title: Anticancer Res
– volume: 15
  start-page: 1177
  year: 1997
  end-page: 1186
  ident: bib20
  article-title: In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI
  publication-title: Magn Reson Imaging
– volume: 19
  start-page: 510
  year: 2001
  end-page: 523
  ident: bib27
  article-title: Magnetic resonance imaging and spectroscopic imaging of prostate cancer
  publication-title: Cancer Invest
– volume: 36
  start-page: 352
  year: 1996
  end-page: 358
  ident: bib21
  article-title: Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy, zonal and age-related differences
  publication-title: Magn Reson Med
– volume: 29
  start-page: 285
  year: 1993
  end-page: 291
  ident: bib40
  article-title: In vitro high resolution
  publication-title: Magn Reson Med
– volume: 123
  start-page: 226
  year: 1996
  ident: 10.1016/j.mri.2006.01.001_bib30
  article-title: Solvent suppression using selective echo dephasing
  publication-title: J Magn Reson A
  doi: 10.1006/jmra.1996.0242
– year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib38
– volume: 17
  start-page: 755
  year: 1999
  ident: 10.1016/j.mri.2006.01.001_bib16
  article-title: In vivo proton magnetic resonance spectroscopy of diseased prostate, spectroscopic features of malignant versus benign pathology
  publication-title: Magn Reson Imaging
  doi: 10.1016/S0730-725X(99)00006-5
– volume: 22
  start-page: 118
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib9
  article-title: Diffusion-weighted magnetic resonance imaging
  publication-title: J Neuroophthalmol
  doi: 10.1097/00041327-200206000-00013
– volume: 37
  start-page: 204
  year: 1997
  ident: 10.1016/j.mri.2006.01.001_bib19
  article-title: Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1910370212
– volume: 85
  start-page: 60
  year: 2000
  ident: 10.1016/j.mri.2006.01.001_bib36
  article-title: International trends and patterns of prostate cancer incidence and mortality
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B
– volume: 22
  start-page: 1205
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib15
  article-title: MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer
  publication-title: Anticancer Res
– volume: 86
  start-page: 123
  year: 2000
  ident: 10.1016/j.mri.2006.01.001_bib39
  article-title: Prostate cancer staging using imaging
  publication-title: BJU Int
  doi: 10.1046/j.1464-410X.2000.00592.x
– volume: 30
  start-page: 2390
  year: 2003
  ident: 10.1016/j.mri.2006.01.001_bib11
  article-title: Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging, a multichannel statistical classifier
  publication-title: Med Phys
  doi: 10.1118/1.1593633
– volume: 52
  start-page: 429
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib25
  article-title: Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(01)02609-8
– ident: 10.1016/j.mri.2006.01.001_bib32
– volume: 168
  start-page: 914
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib2
  article-title: The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)64542-9
– volume: 38
  start-page: 59
  year: 2000
  ident: 10.1016/j.mri.2006.01.001_bib5
  article-title: Imaging prostate cancer
  publication-title: Radiol Clin North Am
  doi: 10.1016/S0033-8389(05)70150-0
– start-page: 3058
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib42
  article-title: Diagnosis and staging of prostate cancer
– volume: 90
  start-page: 473
  year: 2003
  ident: 10.1016/j.mri.2006.01.001_bib1
  article-title: Molecular imaging in prostate cancer
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.10636
– volume: 15
  start-page: 385
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib44
  article-title: Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors
  publication-title: NMR Biomed
  doi: 10.1002/nbm.793
– volume: 12
  start-page: 39
  year: 1999
  ident: 10.1016/j.mri.2006.01.001_bib17
  article-title: In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland
  publication-title: NMR Biomed
  doi: 10.1002/(SICI)1099-1492(199902)12:1<39::AID-NBM543>3.0.CO;2-1
– volume: 21
  start-page: 258
  year: 2005
  ident: 10.1016/j.mri.2006.01.001_bib33
  article-title: Differentiation of non-cancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.20251
– volume: 26
  start-page: 111
  year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib6
  article-title: Endorectal magnetic resonance imaging in local staging of prostate carcinoma
  publication-title: Abdom Imaging
  doi: 10.1007/s002610000142
– volume: 36
  start-page: 352
  year: 1996
  ident: 10.1016/j.mri.2006.01.001_bib21
  article-title: Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy, zonal and age-related differences
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1910360305
– volume: 229
  start-page: 241
  year: 2003
  ident: 10.1016/j.mri.2006.01.001_bib28
  article-title: Transition zone prostate cancer, metabolic characteristics at 1H MR spectroscopic imaging — initial results
  publication-title: Radiology
  doi: 10.1148/radiol.2291021383
– volume: 87
  start-page: 610
  year: 1990
  ident: 10.1016/j.mri.2006.01.001_bib24
  article-title: 1H MR spectroscopy of normal and malignant human prostates in vivo
  publication-title: J Magn Reson
– start-page: 148
  year: 1987
  ident: 10.1016/j.mri.2006.01.001_bib35
  article-title: MR imaging of the prostate gland: normal anatomy
  publication-title: AJR Am J Roentgenol
– volume: 59
  start-page: 269
  year: 2000
  ident: 10.1016/j.mri.2006.01.001_bib41
  article-title: The intermediary metabolism of the prostate, a key to understanding the pathogenesis and progression of prostate malignancy
  publication-title: Oncology
  doi: 10.1159/000012183
– volume: vol. 2
  start-page: 1248
  year: 1986
  ident: 10.1016/j.mri.2006.01.001_bib29
  article-title: Benign prostatic hyperplasia
– volume: 16
  start-page: 196
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib10
  article-title: In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.10139
– start-page: 35
  year: 2003
  ident: 10.1016/j.mri.2006.01.001_bib4
  article-title: Magnetic resonance-guided prostate biopsy
– volume: 19
  start-page: 510
  year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib27
  article-title: Magnetic resonance imaging and spectroscopic imaging of prostate cancer
  publication-title: Cancer Invest
  doi: 10.1081/CNV-100103849
– volume: 52
  start-page: 530
  year: 2004
  ident: 10.1016/j.mri.2006.01.001_bib13
  article-title: In vivo diffusion tensor imaging of the human prostate
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.20190
– volume: 170
  start-page: 69
  year: 2003
  ident: 10.1016/j.mri.2006.01.001_bib3
  article-title: Magnetic resonance imaging and spectroscopic imaging of prostate cancer
  publication-title: J Urol
  doi: 10.1097/01.ju.0000094958.23276.c4
– volume: 13
  start-page: 534
  year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib8
  article-title: Diffusion tensor imaging, concepts and applications
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.1076
– volume: 51
  start-page: 15
  year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib37
  article-title: Cancer statistics
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.51.1.15
– volume: 16
  start-page: 1281
  year: 1998
  ident: 10.1016/j.mri.2006.01.001_bib18
  article-title: In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia, localized proton magnetic resonance spectroscopy using external-body surface coil
  publication-title: Magn Reson Imaging
  doi: 10.1016/S0730-725X(98)00110-6
– volume: 198
  start-page: 795
  year: 1996
  ident: 10.1016/j.mri.2006.01.001_bib31
  article-title: Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution
  publication-title: Radiology
  doi: 10.1148/radiology.198.3.8628874
– volume: 29
  start-page: 285
  year: 1993
  ident: 10.1016/j.mri.2006.01.001_bib40
  article-title: In vitro high resolution 1H-spectroscopy of the human prostate, benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1910290302
– volume: 32
  start-page: 36
  year: 2004
  ident: 10.1016/j.mri.2006.01.001_bib14
  article-title: Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate
  publication-title: Urol Res
  doi: 10.1007/s00240-003-0372-8
– volume: 45
  start-page: 459
  year: 1995
  ident: 10.1016/j.mri.2006.01.001_bib22
  article-title: Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone, detection via localized proton spectroscopy
  publication-title: Urology
  doi: 10.1016/S0090-4295(99)80016-8
– volume: 46
  start-page: 1054
  year: 2001
  ident: 10.1016/j.mri.2006.01.001_bib12
  article-title: Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1298
– volume: 29
  start-page: 38
  year: 1993
  ident: 10.1016/j.mri.2006.01.001_bib23
  article-title: Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5T
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1910290109
– volume: 16
  start-page: 451
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib26
  article-title: Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.10172
– volume: 178
  start-page: 797
  year: 1991
  ident: 10.1016/j.mri.2006.01.001_bib7
  article-title: Prostate cancer, local staging with endorectal surface coil MR imaging
  publication-title: Radiology
  doi: 10.1148/radiology.178.3.1994421
– volume: 92
  start-page: 533
  year: 1964
  ident: 10.1016/j.mri.2006.01.001_bib43
  article-title: The role of citric acid in the physiology of the prostate. 3. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)64003-5
– volume: 15
  start-page: 1177
  year: 1997
  ident: 10.1016/j.mri.2006.01.001_bib20
  article-title: In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI
  publication-title: Magn Reson Imaging
  doi: 10.1016/S0730-725X(97)00182-3
– volume: 16
  start-page: 172
  year: 2002
  ident: 10.1016/j.mri.2006.01.001_bib34
  article-title: Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.10140
SSID ssj0005235
Score 2.039832
Snippet Proton magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI) were carried out in men with increased prostate-specific antigen...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 541
SubjectTerms Aged
Aged, 80 and over
Apparent diffusion coefficient (ADC)
Biomarkers - analysis
Citrate/(Cho+Cr) ratio
Citrates - analysis
Diffusion Magnetic Resonance Imaging - methods
Diffusion-weighted imaging (DWI)
Humans
Magnetic resonance spectroscopic imaging (MRSI)
Magnetic Resonance Spectroscopy - methods
Male
Middle Aged
Prostate cancer
Prostate-specific antigen (PSA)
Prostate-Specific Antigen - blood
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - metabolism
Reproducibility of Results
Sensitivity and Specificity
Statistics as Topic
Tissue Distribution
Title Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0730725X06000257
https://dx.doi.org/10.1016/j.mri.2006.01.001
https://www.ncbi.nlm.nih.gov/pubmed/16735174
https://www.proquest.com/docview/68031159
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1873-5894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005235
  issn: 0730-725X
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1873-5894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005235
  issn: 0730-725X
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1873-5894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005235
  issn: 0730-725X
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-5894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005235
  issn: 0730-725X
  databaseCode: AKRWK
  dateStart: 19820101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT-MwDLdgSCdeENwHjK_Lwz2d1NvSJm33OA3QAIGQOKS99ZLUkYZGN7Hxyt-O3abc3QOcdG9RFatR7Dh2_LMN8C0xDktlTaTLREcqjzm-axkJQPJVlrH1dR731XU6vlMXEz1Zg1GbC8OwyqD7G51ea-vwpRd2s7eYTnu3LJxZrCf9lI-1ztZhg-6fPO_AxvD8cnz9B9Kj6bNJ8yMmaIObNczr4XEaQhKSoxJvXU9vmZ_1NXS2DVvBfhTDZok7sIbVR_hwFSLkn-DXiNttNAA3EUBY4gFXxGvONhY1w5fCVKUYnowE1_rGpZh7seD0DzI8xZTnV4IfaGnMRuUSS3FzOxQzBhh9hruz05-jcRS6KESOfKdVlCufYemdI1dQO4PpIMNkgFqhSQfoncwsV2GngVQaU8wlaq_ILXHkHOokTr5Ap5pXuAfCe7KPjExULFFZaS1qRskpbbyzRsku9NvNK1woMc6dLmZFiyW7L2i_ufVlWvQl4-m68P2VZNHU13hvctxypGgTR0nVFaT93yNSr0R_Sda_yL62LC_oxHEYxVQ4f1oWad7nEkWDLuw2kvB74WmWcOXv_f_75QFsNg88_MZzCJ3V4xMekcmzssew_uNZHgfBfgFP7v5f
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dTxsxDLcYkzZeJsY2KGNrHnhCurW5S-7ax6qAymgREiD1LUtyjlTUXqu2vPK3E9_l-HiASbxFp1gXxY5jxz_bAIeJtpgLoyOZJzISnZjiu4aQAF6-8jw2rszjHl2kgxvxdyzHG9Cvc2EIVhl0f6XTS20dvrTCbrYWk0nrioQzi-W4ndKxltkH-ChknJEH9uf-Oc6j6rLpZ0c0vQ5tliCv2XISAhKcYhKvXU6vGZ_lJXS6DV-C9ch61QK_wgYWO_BpFOLj3-Bfn5ptVPA2FiBYbIZrz2nKNWYlu1dMFznrHfcZVfrGFZs7tqDkD292sgnNLxg9z_oxmZQrzNnlVY9NCV70HW5OT677gyj0UIis95zWUUe4DHNnrXcEpdWYdjNMuigF6rSLzvLMUA12P-BCYoodjtIJ75RY7xrKJE5-wGYxL3APmHPeOtI8ETFHYbgxKAkjJ6R21mjBG9CuN0_ZUGCc-lxMVY0ku1V-v6nxZaranNB0DTh6JFlU1TXemhzXHFF12qhXdMrr_reIxCPRC7n6H1mzZrny542CKLrA-d1KpZ02FSjqNmC3koSnhadZQnW_99_3yyZ8HlyPhmp4dnH-E7aqpx567TmAzfXyDn9542dtfpfC_QBr9v8n
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+between+metabolite+ratios+and+ADC+values+of+prostate+in+men+with+increased+PSA+level&rft.jtitle=Magnetic+resonance+imaging&rft.au=Kumar%2C+Virendra&rft.au=Jagannathan%2C+Naranamangalam+R&rft.au=Kumar%2C+Rajeev&rft.au=Das%2C+Sharat+C&rft.date=2006-06-01&rft.issn=0730-725X&rft.volume=24&rft.issue=5&rft.spage=541&rft_id=info:doi/10.1016%2Fj.mri.2006.01.001&rft_id=info%3Apmid%2F16735174&rft.externalDocID=16735174
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-725X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-725X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-725X&client=summon